Assignee
BIOINVENT INT AB
SE·19 granted patents·19 pending applications·1,443 citations·filing 1994–2025
Top patents by PatentIndex Score
38 records- 0194US6989250B2Method for in vitro molecular evolution of protein functionBIOINVENT INT AB·Filed 2002·Granted Jan 24, 2006·65 cites·49 claims
- 0293US5567610AMethod of producing human monoclonal antibodies and kit thereforBIOINVENT INT AB·Filed 1994·Granted Oct 22, 1996·1.2k cites·11 claims
- 0390US7943744B2ICAM-1 binding antibodiesBIOINVENT INT AB·Filed 2006·Granted May 17, 2011·15 cites·19 claims
- 0488US7521046B2Antibody immunization therapy for treatment of atherosclerosisBIOINVENT INT AB·Filed 2007·Granted Apr 21, 2009·8 cites·4 claims
- 0584US6159690AMethod for in vitro molecular evolution of protein function using exonuclease and amplificationBIOINVENT INT AB·Filed 1998·Granted Dec 12, 2000·65 cites·18 claims
- 0682US5712089AMethod of selecting specific bacteriophagesBIOINVENT INT AB·Filed 1994·Granted Jan 27, 1998·71 cites·8 claims
- 0775US10351970B2Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligandsBIOINVENT INT AB·Filed 2016·Granted Jul 16, 2019·1 cites·21 claims
- 0873US11447549B2Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibodyBIOINVENT INT AB·Filed 2018·Granted Sep 20, 2022·1 cites·14 claims
- 0972US7432083B2Method for in vitro molecular evolution of protein functionBIOINVENT INT AB·Filed 2005·Granted Oct 7, 2008·5 cites·34 claims
- 1071US2025066492A1Agonistic anti tnfr2 antibody moleculesBIOINVENT INT AB·Filed 2024·Application pending·0 cites
- 1169US2025388690A1Novel antagonistic anti-tnfr2 antibodiesBIOINVENT INT AB·Filed 2025·Application pending·0 cites
- 1268US6027930AMethod of selecting specific bacteriophagesBIOINVENT INT AB·Filed 1996·Granted Feb 22, 2000·40 cites·16 claims
- 1364US12291569B2Antibodies and nucleotide sequences, and uses thereofBIOINVENT INT AB·Filed 2019·Granted May 6, 2025·0 cites·8 claims
- 1464US2025257135A1Novel antibodies and nucleotide sequences, and uses thereofBIOINVENT INT AB·Filed 2025·Application pending·0 cites
- 1563US12139547B2Agonistic anti TNFR2 antibody moleculesBIOINVENT INT AB·Filed 2019·Granted Nov 12, 2024·0 cites·29 claims
- 1663US2023058227A1Novel antibodies and combined use of a treg depleting antibody and an immunostimulatory antibodyBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 1762US12441805B2Antagonistic anti-TNFR2 antibodiesBIOINVENT INT AB·Filed 2019·Granted Oct 14, 2025·0 cites·29 claims
- 1861US2014200152A1Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligandsBIOINVENT INT AB·Filed 2013·Application pending·0 cites
- 1960US9803013B2Biological materials and uses thereofBIOINVENT INT AB·Filed 2014·Granted Oct 31, 2017·0 cites·15 claims
- 2059US2026018241A1Methods of isolating anti-ligandsBIOINVENT INT AB·Filed 2023·Application pending·0 cites
- 2158US2024374719A1Novel combinations of antibodies and uses thereofBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 2257US2024301070A1Improving antibody tolerability associated with intravenous administrationBIOINVENT INT AB·Filed 2021·Application pending·0 cites
- 2357US2023322933A1Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodiesBIOINVENT INT AB·Filed 2021·Application pending·0 cites
- 2456US2026001958A1Medicaments, uses and methodsBIOINVENT INT AB·Filed 2025·Application pending·0 cites
- 2554US2015352207A1Use of antibodies against icam-1 in combination with an anti cancer drug in the treatment of patientsBIOINVENT INT AB·Filed 2014·Application pending·0 cites
- 2653US2024092912A1Novel combinations of antibodies and uses thereofBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 2751US2018221482A1Use of antibodies against icam-1 in combination with an anti cancer drug in the treatment of patientsBIOINVENT INT AB·Filed 2017·Application pending·0 cites
- 2849US2010119526A1DLL4 Signaling Inhibitors and Uses ThereofBIOINVENT INT AB·Filed 2008·Application pending·0 cites
- 2947US6495321B1Method for in vitro molecular evolution of protein functionBIOINVENT INT AB·Filed 1998·Granted Dec 17, 2002·9 cites·18 claims
- 3047US2016280788A1Use of antibodies against icam-1 in the treatment of patients with relapsed cancerBIOINVENT INT AB·Filed 2016·Application pending·0 cites
- 3146US12344673B2Medicaments, uses and methodsBIOINVENT INT AB·Filed 2015·Granted Jul 1, 2025·0 cites·14 claims
- 3246US2022259309A1Antibody combinations for treatment of cancer in specific patientsBIOINVENT INT AB·Filed 2020·Application pending·0 cites
- 3345US2009208503A1Immunotherapeutic treatmentBIOINVENT INT AB·Filed 2006·Application pending·0 cites
- 3444US12371498B2Combination and use of antibodiesBIOINVENT INT AB·Filed 2019·Granted Jul 29, 2025·0 cites·16 claims
- 3542US2014242072A1Anti-icam-1 antibodies to treat multiple-myeloma related disordersBIOINVENT INT AB·Filed 2012·Application pending·0 cites
- 3641US2009060915A1Polypeptide, vaccine and use thereofBIOINVENT INT AB·Filed 2006·Application pending·0 cites
- 3731US10191049B2Screening methods and uses thereofBIOINVENT INT AB·Filed 2012·Granted Jan 29, 2019·0 cites·21 claims
- 3827US6607881B1Combined ligand and receptor displayBIOINVENT INT AB·Filed 1996·Granted Aug 19, 2003·2 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when BIOINVENT INT AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →